{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:46:45Z","timestamp":1792010805530,"version":"4.4.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2027,2]]},"DOI":"10.1016\/j.bcmd.2026.103036","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T15:22:24Z","timestamp":1789744944000},"page":"103036","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Real-world experience in management of patients with PNH treated with iptacopan: A case series"],"prefix":"10.1016","volume":"122","author":[{"given":"Mark","family":"Orland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivasa","family":"Sanikommu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelo","family":"Gurnari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dingli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslaw P.","family":"Maciejewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2026.103036_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01157","article-title":"Anti-complement treatment for paroxysmal nocturnal hemoglobinuria: time for proximal complement inhibition? A position paper from the SAAWP of the EBMT","volume":"10","author":"Risitano","year":"2019","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.bcmd.2026.103036_bb0010","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1182\/blood.2019003812","article-title":"How I treat paroxysmal nocturnal hemoglobinuria","volume":"137","author":"Brodsky","year":"2021","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.bcmd.2026.103036_bb0015","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1080\/17512433.2022.2109462","article-title":"The role of the alternative pathway in paroxysmal nocturnal hemoglobinuria and emerging treatments","volume":"15","author":"Lee","year":"2022","journal-title":"Expert. Rev. Clin. Pharmacol."},{"issue":"12","key":"10.1016\/j.bcmd.2026.103036_bb0020","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1038\/s41375-023-02047-z","article-title":"Deciphering treatment patterns in non-severe\/moderate aplastic anemia: an international observational study","volume":"37","author":"Fattizzo","year":"2023","journal-title":"Leukemia"},{"issue":"18","key":"10.1016\/j.bcmd.2026.103036_bb0025","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1182\/blood-2014-02-522128","article-title":"Paroxysmal nocturnal hemoglobinuria","volume":"124","author":"Brodsky","year":"2014","journal-title":"Blood"},{"issue":"10304","key":"10.1016\/j.bcmd.2026.103036_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(21)01542-7","article-title":"Chronic Budd-Chiari syndrome in paroxysmal nocturnal haemoglobinuria","volume":"398","author":"Gurnari","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.bcmd.2026.103036_bb0035","series-title":"Prescribing Information","author":"Soliris","year":"2007"},{"key":"10.1016\/j.bcmd.2026.103036_bb0040","series-title":"Prescribing Information","author":"Ultomiris","year":"2018"},{"key":"10.1016\/j.bcmd.2026.103036_bb0045","series-title":"Prescribing Information","author":"Piasky","year":"2024"},{"key":"10.1016\/j.bcmd.2026.103036_bb0050","series-title":"Prescribing Information","author":"Empaveli","year":"2021"},{"key":"10.1016\/j.bcmd.2026.103036_bb0055","series-title":"Prescribing Information","author":"Voydeya","year":"2024"},{"key":"10.1016\/j.bcmd.2026.103036_bb0060","series-title":"Prescribing Information","author":"Fabhalta (iptacopan)","year":"2023"},{"issue":"11","key":"10.1016\/j.bcmd.2026.103036_bb0065","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMoa2308695","article-title":"Oral iptacopan monotherapy in paroxysmal nocturnal hemoglobinuria","volume":"390","author":"Peffault de Latour","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bcmd.2026.103036_bb0070","doi-asserted-by":"crossref","DOI":"10.1080\/16078454.2024.2329030","article-title":"Expert consensus on the management of pharmacodynamic breakthrough-hemolysis in treated paroxysmal nocturnal hemoglobinuria","volume":"29","author":"Dingli","year":"2024","journal-title":"Hematology"},{"issue":"2","key":"10.1016\/j.bcmd.2026.103036_bb0075","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1056\/NEJMra2201664","article-title":"Breakthrough hemolysis in PNH with proximal or terminal complement inhibition","volume":"387","author":"Notaro","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2026.103036_bb0080","doi-asserted-by":"crossref","first-page":"e414","DOI":"10.1016\/S2352-3026(25)00081-X","volume":"12","author":"Risitano","year":"2025","journal-title":"Lancet Haematol."},{"issue":"2","key":"10.1016\/j.bcmd.2026.103036_bb0085","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1182\/blood.2024023988","article-title":"Paroxysmal nocturnal hemoglobinuria-related thrombosis in the era of novel therapies: a 2043-patient-year analysis","volume":"144","author":"Gurnari","year":"2024","journal-title":"Blood"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979626000598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979626000598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:07:45Z","timestamp":1792008465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979626000598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,2]]},"references-count":17,"alternative-id":["S1079979626000598"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2026.103036","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2027,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world experience in management of patients with PNH treated with iptacopan: A case series","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2026.103036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103036"}}